Innovate Biopharmaceuticals, Inc. (1551986) SEC Filing 8-K Material Event for the period ending Wednesday, April 29, 2020

Univest Corp Of Pennsylvania

CIK: 1551986 Ticker: UVSP

View differences made from one to another to evaluate Univest Corp Of Pennsylvania's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Univest Corp Of Pennsylvania.


Assess how Univest Corp Of Pennsylvania's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Univest Corp Of Pennsylvania's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors